KeyanooshHosseinzadehMD
Radiology • Winston Salem, NCAssistant Professor, Radiology, University of Pittsburgh School of Medicine
Are you Dr. Hosseinzadeh?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
S Hawthorne Rd
Winston Salem, NC 27157Phone+1 336-716-2255
Summary
- Dr. Keyanoosh Hosseinzadeh, MD is a board certified radiologist in Winston Salem, North Carolina. He is currently licensed to practice medicine in North Carolina, Pennsylvania, and Maryland. He is affiliated with Wake Forest Baptist Health-Lexington Medical Center and is an Assistant Professor at University of Pittsburgh School of Medicine.
Education & Training
University of Western OntarioClass of 1992
Certifications & Licensure
NC State Medical License 2013 - 2025
PA State Medical License 2005 - 2014
MD State Medical License 1999 - 2006
DC State Medical License 1997 - 2004
American Board of Radiology Diagnostic Radiology
Publications & Presentations
PubMed
- 123 citationsSafety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, ope...Angela Tatiana Alistar, Bonny Morris, Rodwige Desnoyer, Heidi D. Klepin, Keyanoosh Hosseinzadeh
The Lancet. Oncology. 2017-06-01 - 7 citationsACR Appropriateness Criteria® Hematospermia.Keyanoosh Hosseinzadeh, Aytekin Oto, Brian C. Allen, Fergus V. Coakley, Barak Friedman
Journal of the American College of Radiology. 2017-05-01 - 39 citationsEvaluating skeletal dysplasias on prenatal ultrasound: an emphasis on predicting lethality.Kathryn S. Milks, Lyndon M. Hill, Keyanoosh Hosseinzadeh
Pediatric Radiology. 2017-02-01
Authored Content
- ACR Appropriateness Criteria® Pretreatment Staging of Muscle-Invasive Bladder CancerMay 2018
- ACR Appropriateness Criteria® Pretreatment Staging of Muscle-Invasive Bladder CancerMay 2018
